395 related articles for article (PubMed ID: 27490411)
41. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
Bernardi M; Gitto S; Biselli M
J Hepatol; 2011 Jun; 54(6):1297-306. PubMed ID: 21145851
[TBL] [Abstract][Full Text] [Related]
42. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.
Lai JC; Covinsky KE; Hayssen H; Lizaola B; Dodge JL; Roberts JP; Terrault NA; Feng S
Liver Int; 2015 Sep; 35(9):2167-73. PubMed ID: 25644788
[TBL] [Abstract][Full Text] [Related]
43. MELD as a metric for survival benefit of liver transplantation.
Luo X; Leanza J; Massie AB; Garonzik-Wang JM; Haugen CE; Gentry SE; Ottmann SE; Segev DL
Am J Transplant; 2018 May; 18(5):1231-1237. PubMed ID: 29316310
[TBL] [Abstract][Full Text] [Related]
44. Improving Liver Allocation Using Optimized Neighborhoods.
Kilambi V; Mehrotra S
Transplantation; 2017 Feb; 101(2):350-359. PubMed ID: 27906775
[TBL] [Abstract][Full Text] [Related]
45. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
[TBL] [Abstract][Full Text] [Related]
46. Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas.
Molinari M; Renfrew PD; Petrie NM; De Coutere S; Abdolell M
Transpl Int; 2011 Mar; 24(3):292-9. PubMed ID: 21143650
[TBL] [Abstract][Full Text] [Related]
47. A model including standardized weight improved predicting waiting list mortality in adolescent liver transplant candidates: A US national study.
Shaheen AA; Martin SR; Khorsheed S; Abraldes JG
Liver Transpl; 2024 Mar; 30(3):269-276. PubMed ID: 37655999
[TBL] [Abstract][Full Text] [Related]
48. Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival.
Malik AK; Masson S; Allen E; Akyol M; Bathgate A; Davies M; Hidalgo E; Hudson M; Powell J; Taylor R; Zarankaite A; Manas DM;
Transplantation; 2019 Nov; 103(11):2304-2311. PubMed ID: 30830042
[TBL] [Abstract][Full Text] [Related]
49. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
[TBL] [Abstract][Full Text] [Related]
50. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
[TBL] [Abstract][Full Text] [Related]
51. Access to Liver Transplantation in Different ABO-Blood Groups and "Exceptions Points" in a Model for End-Stage Liver Disease Allocation System: A Brazilian Single-Center Study.
Martino RB; Waisberg DR; Dias APM; Inoue VBS; Arantes RM; Haddad LBP; Rocha-Santos V; Pinheiro RSN; Nacif LS; D'Albuquerque LAC
Transplant Proc; 2018 Apr; 50(3):754-757. PubMed ID: 29661430
[TBL] [Abstract][Full Text] [Related]
52. United Network for Organ Sharing regional variations in appeal denial rates with non-standard Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exceptions: support for a national review board.
Gish RG; Wong RJ; Honerkamp-Smith G; Xu R; Osorio RW
Clin Transplant; 2015 Jun; 29(6):513-22. PubMed ID: 25808918
[TBL] [Abstract][Full Text] [Related]
53. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
Wong RJ; Gish RG; Ahmed A
Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
[TBL] [Abstract][Full Text] [Related]
54. Geographic differences in access to transplantation in the United States.
Ellison MD; Edwards LB; Edwards EB; Barker CF
Transplantation; 2003 Nov; 76(9):1389-94. PubMed ID: 14627922
[TBL] [Abstract][Full Text] [Related]
55. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate.
Myers RP; Shaheen AA; Aspinall AI; Quinn RR; Burak KW
J Hepatol; 2011 Mar; 54(3):462-70. PubMed ID: 21109324
[TBL] [Abstract][Full Text] [Related]
56. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
Malamon JS; Kaplan B; Jackson WE; Saben JL; Schold JD; Pomfret EA; Pomposelli JJ
Int J Surg; 2023 Sep; 109(9):2714-2720. PubMed ID: 37226874
[TBL] [Abstract][Full Text] [Related]
57. Impact of Acuity Circles on Outcomes for Pediatric Liver Transplant Candidates.
Mogul DB; Perito ER; Wood N; Mazariegos GV; VanDerwerken D; Ibrahim SH; Mohammad S; Valentino PL; Gentry S; Hsu E
Transplantation; 2020 Aug; 104(8):1627-1632. PubMed ID: 32732840
[TBL] [Abstract][Full Text] [Related]
58. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
[TBL] [Abstract][Full Text] [Related]
59. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
[TBL] [Abstract][Full Text] [Related]
60. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.
Myers RP; Shaheen AA; Faris P; Aspinall AI; Burak KW
PLoS One; 2013; 8(1):e51926. PubMed ID: 23349678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]